We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Brazil’s Anvisa Suspends Deadline for New Drug Tracking Program
Brazil’s Anvisa Suspends Deadline for New Drug Tracking Program
The board of directors of Brazil’s Anvisa has suspended the deadline for companies to submit data for a new drug tracking system and is repealing the system’s implementing legislation.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor